SCHEMBL5068458

SCHEMBL5068458

CCCc1ccc(C(=S)Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.50
POLB P06746 3/20 0.49
CTDSP1 Q9GZU7 3/20 0.49
ALDH1A1 P00352 3/20 0.49
GAA P10253 2/20 0.49
KDM4E B2RXH2 1/20 0.49
THRB P10828 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
LPL P06858 1/20 0.47
LIPG Q9Y5X9 1/20 0.47
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CNR2 P34972 2/20 0.41
CNR1 P21554 1/20 0.41
THRA P10827 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8679873 0.88 RARB (0.53) PLK1ALDH1A1KDM4ETHRBESR1
SCHEMBL8679652 0.82 SMN1; SMN2 (0.61) PLK1POLBALDH1A1GAAL3MBTL1
SCHEMBL28783796 0.80 L3MBTL1 (0.53) PLK1POLBCTDSP1ALDH1A1GAA
SCHEMBL9338315 0.80 PLK1 (0.52) PLK1POLBCTDSP1ALDH1A1GAA
SCHEMBL9098955 0.80 THRB (0.55) PLK1POLBCTDSP1ALDH1A1GAA
SCHEMBL6404791 0.78 PLK1 (0.50) PLK1POLBCTDSP1ALDH1A1GAA
SCHEMBL1019681 0.78 PLK1 (0.60) PLK1POLBCTDSP1ALDH1A1GAA
SCHEMBL10871765 0.78 PLK1 (0.55) PLK1POLBCTDSP1ALDH1A1GAA
SCHEMBL7897931 0.78 SMN1; SMN2 (0.69) PLK1POLBCTDSP1ALDH1A1GAA
Hydrochloric Acid SCHEMBL7895919 0.78 L3MBTL1 (0.52) PLK1POLBCTDSP1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1043299-B1 Liquid crystalline compound, liquid crystal composition comprising the liquid crystalline compound, and liquid crystal display device using the liquid crystal composition CHISSO CORP (JP) 2008-10-15 EP disclosed
EP-0893423-B1 LIQUID CRYSTAL COMPOUNDS HAVING FLUORINATED LINKAGES, LIQUID CRYSTAL COMPOSITIONS, AND LIQUID CRYSTAL DISPLAY DEVICES CHISSO CORP (JP) 2004-09-01 EP disclosed
EP-0916639-B1 LIQUID CRYSTAL COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS CONTAINING THE COMPOUNDS, AND LIQUID CRYSTAL DISPLAY DEVICES MADE BY USING THE COMPOSITIONS CHISSO CORP (JP) 2002-06-12 EP disclosed
US-6319570-B1 LIQUID CRYSTALS AND VISUAL AIDS FILM TRANSISTOR (TFT) DISPLAY MODE DEVELOP PREFERABLE PHYSICAL PROPERTIES CHISSO CORPORATION (JP) 2001-11-20 US disclosed
US-6190576-B1 MIXTURES CHISSO CORPORATION (JP) 2001-02-20 US disclosed
US-6177154-B1 MISCIBILITY; LOW IN THRESHOLD VOLTAGE, INDUCE LARGE PRETILT ANGLE, HIGH IN VOLTAGE HOLDING RATIO AND ARE LOW IN ITS DEPENDENCY ON TEMPERATURE CHISSO CORPORATION (JP) 2001-01-23 US disclosed
EP-1043299-A2 Liquid crystalline compound, liquid crystal composition comprising the liquid crystalline compound, and liquid crystal display device using the liquid crystal composition CHISSO CORPORATION (JP) 2000-10-11 EP disclosed
EP-0916639-A1 LIQUID CRYSTAL COMPOUNDS, LIQUID CRYSTAL COMPOSITIONS CONTAINING THE COMPOUNDS, AND LIQUID CRYSTAL DISPLAY DEVICES MADE BY USING THE COMPOSITIONS CHISSO CORPORATION (JP) 1999-05-19 EP disclosed
EP-0893423-A1 LIQUID CRYSTAL COMPOUNDS HAVING FLUORINATED LINKAGES, LIQUID CRYSTAL COMPOSITIONS, AND LIQUID CRYSTAL DISPLAY DEVICES CHISSO CORPORATION (JP) 1999-01-27 EP disclosed
WO-1998037052-A1 PREPARATION OF ARYL BROMOARYL KETONES AND CARBOXYLIC DERIVATIVES THEREOF ALBEMARLE CORPORATION (US) 1998-08-27 WO disclosed
EP-0041711-B1 6-CHLORO- OR 6-BROMO-1,2-DIHYDRO-3H-PYRROLO(1,2-A)-PYRROLE-1-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYNTEX (U.S.A.) INC. (US) 1985-04-17 EP disclosed
US-4410534-A 3-Substituted-5,6,7,8-tetrahydropyrrolo[1,2-a]-pyridine-and 6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]-azepine carboxylic acid derivatives useful as blood platelet aggregation inhibitors SYNTEX (U.S.A.) INC. (US) 1983-10-18 US disclosed
US-4344943-A ANALGESICS, ANTIINFLAMMATORY AGENTS SYNTEX (U.S.A.) INC. (US) 1982-08-17 US disclosed
EP-0041711-A1 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo(1,2-a)-pyrrole-1-carboxylic acids and derivatives thereof, process for their production and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1981-12-16 EP disclosed
US-4232038-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS, AND MUSCLE RELAXANTS SYNTEX (U.S.A.) INC. (US) 1980-11-04 US disclosed